Lymphoma trial finds combination targeted therapy effective prior...
ABSTRACT #7508
Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that...
Combination checkpoint blockade effective in pre-surgical...
ABSTRACT 8504
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic...
Ribociclib plus hormone therapy extends survival for...
ABSTRACT LBA1008
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in...
Study reports ibrutinib and venetoclax combo effective as...
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown to be effective when...
Texas raises tobacco sales age to 21 to limit youth...
The University of Texas MD Anderson Cancer Center applauds the Texas Legislature today for passing Senate Bill 21, which raises the...
David Jaffray, Ph.D., Named Chief Technology and Digital...
The University of Texas MD Anderson Cancer Center today named David Jaffray, Ph.D., as its first-ever chief technology and digital...
Polo on the Prairie raises $775,000 for cancer research,...
Despite a Saturday morning storm that wreaked havoc on plans for this year’s Polo on the Prairie, May 18 at the Musselman Brothers’...
Ipilimumab and nivolumab immunotherapy combination produces...
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response rate for patients with metastatic...
MD Anderson applauds Texas Legislature for authorizing...
The University of Texas MD Anderson Cancer Center applauds the 86th Texas Legislature today for voting to approve a constitutional...
MD Anderson leadership development program receives...
The University of Texas MD Anderson Cancer Center has received full accreditation by the American Association for Physician...
Study shows MD Anderson-developed drug effective in...
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered...
2019 Andrew Sabin Family Fellows share passion for Making...
The University of Texas MD Anderson Cancer Center has named eight researchers to the fourth annual class of Andrew Sabin Family...
New cancer therapy target found in mitochondria for...
A study at The University of Texas MD Anderson Cancer Center identified a new therapeutic target in cancer cells and explains how new...